Clinical Research, Pharma & Healthcare FinancingPfizer and Astellas’ PADCEV® + KEYTRUDA® Shows Long-Term EfficacyBusiness WireFebruary 11, 2025February 12, 2025 by Business WireFebruary 11, 2025February 12, 2025040 Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) today announced additional follow-up results from the Phase 3...
